Thomas Krey

Medizinische Hochschule Hannover — Germany

Medicine · Health Sciences

34h-index4.4kcitations119works7.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatitis C virus research(33), Monoclonal and Polyclonal Antibodies Research(32), Hepatitis B Virus Studies(23), SARS-CoV-2 and COVID-19 Research(14), Viral Infectious Diseases and Gene Expression in Insects(11)

Publications119 total

Design and Analysis of Novel <scp>HEV</scp> Vaccine Variants and Evaluation of Two Selected Candidates in a Porcine Infection Model
Liver International·2025· 1 citedOpen Access
A critical residue in a conserved RBD epitope determines neutralization breadth of pan-sarbecovirus antibodies with recurring YYDRxxG motifs
mBio·2025Open Access
Identification of the human cytomegalovirus gHgLgO trimer as the central player in virion infectivity
PLoS Pathogens·2025Open Access
Broadly neutralizing antibodies isolated from HEV convalescents confer protective effects in human liver-chimeric mice
Nature Communications·2025· 9 citedOpen Access
Computationally designed stem-epitope mimetics elicit broadly reactive antibodies
2025Open Access
Epitope-focused immunogens targeting the hepatitis C virus glycoproteins induce broadly neutralizing antibodies
Science Advances·2024· 5 citedOpen Access
A dual role in virion attachment and entry makes the human cytomegalovirus gHgLgO trimer the central player in virion infectivity
2024Open Access
A human monoclonal antibody neutralizing SARS-CoV-2 Omicron variants containing the L452R mutation
Journal of Virology·2024· 9 citedOpen Access
Human tetraspanin CD81 facilitates invasion of <i>Salmonella enterica</i> into human epithelial cells
Virulence·2024· 2 citedOpen Access
Viral modulation of type II interferon increases T cell adhesion and virus spread
Nature Communications·2024· 10 citedOpen Access
Targeting cellular cathepsins inhibits hepatitis E virus entry
Hepatology·2024· 18 citedOpen Access
Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitor
Nature Communications·2024· 34 citedOpen Access
Viral modulation of type II interferon increases T cell adhesion and virus spread
2023· 2 citedOpen Access
Structural insights into hepatitis C virus neutralization
Current Opinion in Virology·2023· 5 cited
mRNA based expression of Hepatitis E specific neutralizing antibodies in liver cells as therapeutic option
Zeitschrift für Gastroenterologie·2023
The Interplay of antigen and antibody in HEV infection
Zeitschrift für Gastroenterologie·2023
Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination
Science Immunology·2022· 259 citedOpen Access
Binding of Glycans to the SARS CoV‐2 Spike Protein, an Open Question: NMR Data on Binding Site Localization, Affinity, and Selectivity
Chemistry - A European Journal·2022· 11 citedOpen Access
BNT162b2-boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19
Nature Communications·2022· 44 citedOpen Access
A CMV-induced adaptive human Vδ1+ γδ T cell clone recognizes HLA-DR
The Journal of Experimental Medicine·2022· 36 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

F.A. Rey(19), George Ssebyatika(8), Till Rümenapf(8), L.J. Stroh(8), Steven K. H. Foung(6), Alexander W. Tarr(6), Thomas Pietschmann(6), Annalisa Meola(5), Richard J. P. Brown(5), Dorothea Bankwitz(5), Heinz‐Jürgen Thiel(4), Jonathan K. Ball(4), Daniel Tödt(4), Joana Barros‐Martins(3), Swantje I. Hammerschmidt(3), Ivan Odak(3), Christiane Ritter(3), Stefanie Willenzon(3), Anja Bubke(3), Jasmin Ristenpart(3)